EICHOR
● Active Not Recruiting
Weight Loss in People Living With Overweight or Obesity and Type 2 Diabetes Following Treatment With Cagrilintide
Condition: Overweight · Obesity · Type 2 Diabetes · Sponsor: Novo Nordisk A/S
About this study
This study will look at how much cagrilintide helps people with overweight or obesity and type 2 diabetes lower their body weight. Cagrilintide is a new investigational medicine. Doctors may not yet prescribe cagrilintide. Participant will either get cagrilintide or placebo. Which treatment participant get is decided by chance. Participants are two times more likely to get cagrilintide than placebo. Like all medicines, the study medicine may have side effects. For each participant, the study will last for about 1 year and 6 months.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (67)
| Univ of Alabama_Birmingham | Birmingham, Alabama, United States | — |
| Chambliss Clinical Trials, LLC | Montgomery, Alabama, United States | — |
| Noble Clinical Research | Tucson, Arizona, United States | — |
| Scripps Whittier Diabetes Inst | La Jolla, California, United States | — |
| Headlands Research CTR Lincoln | Lincoln, California, United States | — |
| Pacific Clinical Studies | Los Alamitos, California, United States | — |
| Walgreens - Store 4442 | Kissimmee, Florida, United States | — |
| Optimal Research Sites | Orange City, Florida, United States | — |
| Center for Diab,Obes & Metab | Pembroke Pines, Florida, United States | — |
| Palm Beach Research Center | West Palm Beach, Florida, United States | — |
| East West Med Res Inst | Honolulu, Hawaii, United States | — |
| MediSphere Medical RC | Evansville, Indiana, United States | — |
+ 55 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07220759